PAPER Boiangiu RS, Mihasan M, Gorgan DL, Stache BA, Hritcu L

Anxiolytic, Promnesic, Anti-Acetylcholinesterase and Antioxidant Effects of Cotinine and 6-Hydroxy-L-Nicotine in Scopolamine-Induced Zebrafish (Danio rerio) Model of Alzheimer's Disease.

Antioxidants (Basel). 2021 Feb 1;10(2) PubMed: 33535660

PAPER Kanach C, Blusztajn JK, Fischer A, Delalle I

MicroRNAs as Candidate Biomarkers for Alzheimer's Disease.

Noncoding RNA. 2021 Feb 1;7(1) PubMed: 33535543

PAPER Nam Y, Shin SJ, Park YH, Kim MJ, Jeon SG, Lee H, Choi Y, Kim TJ, Shin SM, Kim JJ, Yoo DH, Kim HD, Kim S, Moon M

Platycodon grandiflorum Root Protects against Aβ-Induced Cognitive Dysfunction and Pathology in Female Models of Alzheimer's Disease.

Antioxidants (Basel). 2021 Feb 1;10(2) PubMed: 33535469

PAPER Gokcal E, Horn MJ, van Veluw SJ, Frau-Pascual A, Das AS, Pasi M, Fotiadis P, Warren AD, Schwab K, Rosand J, Viswanathan A, Polimeni JR, Greenberg SM, Gurol ME

Lacunes, Microinfarcts, and Vascular Dysfunction in Cerebral Amyloid Angiopathy.

Neurology. 2021 Mar 23;96(12):e1646-e1654. Epub 2021 Feb 3 PubMed: 33536272

PAPER Koemans EA, Voigt S, Rasing I, Jolink W, van Harten TW, van der Grond J, van Rooden S, Schreuder F, Freeze WM, van Buchem MA, van Zwet EW, van Veluw SJ, Terwindt GM, van Osch M, Klijn C, van Walderveen M, Wermer M

Striped occipital cortex and intragyral hemorrhage: Novel magnetic resonance imaging markers for cerebral amyloid angiopathy.

Int J Stroke. 2021 Feb 3;:1747493021991961. PubMed: 33535905

PAPER Boo YY, Jutila OE, Cupp MA, Manikam L, Cho SI

The identification of established modifiable mid-life risk factors for cardiovascular disease which contribute to cognitive decline: Korean Longitudinal Study of Aging (KLoSA).

Aging Clin Exp Res. 2021 Feb 4; PubMed: 33538990

PAPER Barulli MR, Piccininni M, Brugnolo A, Musarò C, Di Dio C, Capozzo R, Tortelli R, Lucca U, Logroscino G

The Italian Version of the Test Your Memory (TYM-I): A Tool to Detect Mild Cognitive Impairment in the Clinical Setting.

Front Psychol. 2020;11:614920. Epub 2021 Jan 18 PubMed: 33536981

PAPER Raghuvanshi R, Bharate SB

Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.

J Med Chem. 2022 Jan 27;65(2):893-921. Epub 2021 Feb 4 PubMed: 33539089

PAPER Zhou KX, He XT, Hu XF, Zhao WJ, Li CX, Zhang C, Zhang T, Gu ZX, Deng JP, Dong YL

XPro1595 ameliorates bone cancer pain in rats via inhibiting p38-mediated glial cell activation and neuroinflammation in the spinal dorsal horn.

Brain Res Bull. 2019 Jul;149:137-147. Epub 2019 Apr 16 PubMed: 31002915

PAPER McGregor C, Sabatier M, English A

Early regeneration of axons following peripheral nerve injury is enhanced if p75NTR is eliminated from the surrounding pathway.

Eur J Neurosci. 2021 Jan;53(2):663-672. Epub 2020 Sep 9 PubMed: 32812660

Taiwan FDA Approves MagQu Plasma Aβ And Tau Tests

RESEARCH NEWS 2021-02-05 Research News There is an update in the world of Alzheimer’s disease blood tests. This January, the Taiwan Food and Drug Administration approved three immunoassays developed by the biotech company MagQu Co., based in New Taipei City, that measure Aβ40, Aβ

Healthy Ageing (Virtual Meeting)

CONFERENCE 2022-05-25 00:00:00-2022-05-27 00:00:00 Hinxton, England 25 May 2022 to 27 May 2022 View Conference Website 0

PAPER Yang Sh, Liu HC, Lin CY, Chiu MJ, Chen TF, Lin CH, Chen HH

Development of Assaying Plasma TDP-43 Utilizing Immunomagnetic Reduction

Journal of Neurological Disorders. November 4, 2020.

Caroline Pantazis

Are the Long Aβ Peptides the Real Bad Guys?

RESEARCH NEWS 2021-02-05 Research News Mutations in the transmembrane domain of Aβ-protein precursor cause early onset familial Alzheimer’s disease. They can increase the ratio of the amyloidogenic Aβ42 to the less-sticky Aβ40, but how exactly do these FAD mutations alter the pro